21627 ⎘
Preparations for testing
RADIOPHARMACEUTICAL MOFS FOR MEDICAL IMAGING
#2SOMATOSTATIN RECEPTOR-TARGETING RADIOPHARMACEUTICALS AND USES THEREOF
#3NEW PET TRACER FOR IMAGING OF THE FUNCTIONAL HEPATIC RESERVE
#4SIGMA-1 COMPOUNDS, RADIOLIGANDS, AND RELATED METHODS OF USE
#5Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds
#6RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF
#7ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#8PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF
#9TRIFUNCTIONAL COMPOUND AND USE THEREOF
#10FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF
#11HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#12SYNTHETIC CANCER-SPECIFIC PROMOTERS
#13CD138/SYNDECAN1 ANTIBODIES AND METHODS OF USE THEREOF
#14Mouse Anti-Human Monoclonal Antibody Against Glypican-3
#15RADIOPHARMACEUTICALS TARGETING CARBONIC ANHYDRASE IX PROTEINS
#16RADIOLABELED FRUCTOSE DERIVATIVES FOR MEDICAL IMAGING
#17[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#18CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY
#19CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY
#20Fibroblast Activation Protein Alpha-Cleavable Pro-Peptides and Methods of Use
#21PET IMAGING OF BACTERIAL INFECTION WITH A PET PROBE
#22PREVENTION AND/OR TREATMENT OF CARDIAC DAMAGE
#23USE OF EXOSOME, COMPLEX COMPRISING EXOSOME, TRACER, AND PREPARATION METHOD THEREOF
#24PHYTIC ACID-BASED TERNARY COMPLEX BIOMIMETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF
#25Peptide Composition for Cancer Approach and Diagnosis
#26USES OF PSMA-TARGETING AND TSPO-TARGETING COMPOUNDS FOR EVALUATION OF INJURIES IN THE PERIPHERAL NERVOUS SYSTEM
#27APPARATUS AND METHOD FOR MONITORING DISEASE
#28NOVEL COMPOUNDS FOR THE DIAGNOSIS OF TDP-43 PROTEINOPATHIES
#29CD8b-BINDING POLYPEPTIDES
#30GONADOTROPIN-RELEASING HORMONE RECEPTOR (GnRHR) TARGETED THERAPEUTICS AND USES THEREOF
#31DIAGNOSTIC PET IMAGING OF CARDIAC AMYLOIDOSIS
#32METHOD FOR DETECTING INNATE IMMUNE ACTION IN VIVO USING GPR84-PET
#33COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF
#34PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF
#35GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF
#36METHODS AND COMPOSITIONS FOR IMAGING MALIGNANCIES IN THE BONE MARROW
#37Targeted Delivery of Theranostic Agents
#38METHOD FOR INCREASING DISPERSION STABILITY OF NANOPARTICLES AS T1 MRI CONTRAST AGENT AND T1 MRI CONTRAST NANOPARTICLES
#39IMAGING OF BRAIN LESIONS
#40MULTI-TARGETING COMPOUND AND USE THEREOF
#41FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING AND USE THEREOF IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES
#42ZWITTERIONIC COMPOUNDS AND USES THEREOF
#43LIGAND COMPOUND TARGETING PSMA ANTIGEN, AND CHELATE AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#44CYCLIC PEPTIDE AND PREPARATION METHOD THEREFOR, AND COMPLEX COMPRISING SAME AND USE THEREOF
#45FIBROBLAST ACTIVATION PROTEIN (FAP) INHIBITORS, FAP CONJUGATES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#46PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED DEEP-TUMOR PENETRATION OF POLYMER NANODRUGS AND METHODS OF USE THEREOF
#47HETERODIMER AND RADIOACTIVE MEDICAL USE THEREOF
#48DIMERIC RADIOPHARMACEUTICALS, COMPOSITIONS THEREOF AND USES THEREOF
#49METHODS FOR LARGE SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES
#50GENERATION OF SYNTHETIC CONTRAST-ENHANCED RADIOLOGICAL IMAGES
#51RADIOISOTOPE DELIVERY SYSTEM WITH MULTIPLE DETECTORS TO DETECT GAMMA AND BETA EMISSIONS
#52FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS
#53LEAKY JOINT SYNDROME DIAGNOSTICS AND TREATMENTS
#54PET TRACER FOR DETECTION OF TRANSFORMING GROWTH FACTOR BETA
#55HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME
#56RADIOPAQUE HYDROLYSABLE HYDROGELS AND METHODS OF TREATMENT USING SAME
#57RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF
#58Radiotracer Labeling and Administration Methods and System
#595T4 BINDING POLYPEPTIDES AND USES THEREOF
#60PET RADIOLIGANDS FOR IMAGING GLUTAMINYL CYCLASE ACTIVITY
#61CD73 (NT5E) TARGETING POLYPEPTIDES
#62BRAND-NEW SKELETON 99MTC-FAPI DIAGNOSTIC PROBE AND USE THEREOF IN PREPARATION OF DRUG OR REAGENT FOR DIAGNOSING TUMORS
#63POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF
#64PROCESS FOR PREPARATION OF RADIOLABELED STYRYLPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#65COMPOUNDS FOR COATING OF NANOSTRUCTURES
#66IN VIVO TRANSITION METAL DETECTION
#67MYOCARDITIS-TARGETED RADIONUCLIDE MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#68PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS
#69THERANOSTIC FOR TREATING CANCER
#70DUAL MODE RADIOTRACER AND -THERAPEUTICS
#71FIBROBLAST ACTIVATION PROTEIN TARGETING PRECURSOR AND RADIOTRACER
#72PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
#73RADIOLABELLING KIT AND METHOD FOR RADIOLABELLING
#74Central Neurodegeneration Imaging Agent and Method of Preparing the Same
#75N-Cyclopropyl-1-(4-(4-(Fluoro-18f)Phenyl)Pyrimidin-5-Yl)-N-Methylpiperidine- 4-Carboxamide and Uses in PET Imaging
#76NEURON TARGETED 2-DEOXYGLUCOSE DENDRIMER FOR IMAGING AND TREATMENT OF NEUROLOGICAL DISEASES
#77COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER
#78BINDING PROTEIN
#79SINGLE-DOMAIN HIGH AFFINITY ANTIBODIES AND METHODS OF USE THEREOF
#80CD3 TARGETING ANTIBODIES AND USES THEREOF
#81HUMAN ANTIBODIES AND USES THEREOF
#82CHROMANE IMAGING LIGANDS
#83RADIOIMMUNOCONJUGATES TARGETING PHOSPHATIDYLSERINE FOR USE IN THE TREATMENT OF CANCER
#84CARBONIC ANHYDRASE IX LIGANDS
#85PRECURSOR AND RADIOTRACER FOR NEUROENDOCRINE THERANOSTICS
#86COMPOUNDS WITH IMPROVED PHARMACOKINETICS FOR IMAGING AND THERAPY OF CANCER
#87METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS
#88ANTITUMOR AGENT, IMAGE GENERATION METHOD, BACTERIUM, AND PRODUCTION METHOD
#89HER2 TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
#90ZWITTERIONIC METAL CHELATORS
#91ZWITTERIONIC METAL CHELATORS
#92PSMA-TARGETING LIGANDS FOR MULTIMODAL APPLICATIONS
#93RADIOLABELED LIPOSOMES AND METHODS OF USE FOR TREATING LEPTOMENINGEAL METASTASES
#94DISEASE-TARGETED IMAGING AGENTS
#95COVALENT FLUORESCENT PROBES FOR CANNABINOID RECEPTOR 2
#96APTAMER, CONJUGATE, COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF
#97UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCCS)
#98FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS
#99SYSTEMS AND METHODS FOR IMPROVED TRANSPORT AND DISTRIBUTION OF AGENTS IN AND CHARACTERIZATION OF BIOLOGICAL TISSUE
#100RADIOPHARMACEUTICALS WITH HIGH STABILITY AND RADIOLABELING EFFICIENCY AND THERANOSTIC KIT COMPRISING SAID RADIOPHARMACEUTICALS
#101PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED RENAL CLEARANCE
#102GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS
#103B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF
#104MICROFLUIDIC PREPARATION OF DUAL-PHASE NANODROPLETS WITH FLUORINATED COMPOUNDS
#105ICAM-1 TARGETED CAR CONSTRUCTS AND METHODS OF TREATMENT
#106HER2 TARGETING FC ANTIGEN BINDING FRAGMENT-DRUG CONJUGATES
#107CAR CONSTRUCTS AND METHODS OF TREATMENT
#108[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#109[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#110[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#111PHOSPHORAMIDATE-BASED PSMA-TARGETED SMALL-MOLECULE DRUG CONJUGATES
#112ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF
#113AGENTS FOR TREATMENT OF ENDOMETRIOSIS AND OTHER BENIGN GYNECOLOGICAL NEOPLASMS
#114TRISLINKER-CONJUGATED DIMERIC LABELING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM
#115USE OF SECOND NEAR-INFRARED ORGANIC FLUORESCENT COMPOUND IN PREPARATION OF BIOIMAGING CONTRAST AGENT AND IN VASCULAR FLUORESCENCE IMAGING
#116Metallophore-Radionuclide Complex as Nuclear Imaging Contrast Agents
#117PROBES FOR CELLULAR SENESCENCE
#118Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof
#119TRACER COMPOSITION FOR RADIOACTIVE PET DIAGNOSIS, INTERMEDIATE THEREOF, AND PRODUCTION METHOD THEREOF
#120TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR
#121SCISSION-ENHANCED NUCLEAR IMAGING AND TREATMENT
#122RADIOPHARMACEUTICAL COMPOSITIONS, SYNTHETIC METHODS, AND METHODS OF TREATMENT
#123RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS
#124GLOBULAR NANOSTRUCTURES HAVING AN ANCHORING LAYER
#125METHODS OF TREATING SMALL CELL LUNG CANCER
#126GLOBULAR NANOSTRUCTURES
#127ONE-STEP SUPRAMOLECULAR MULTIFUNCTIONAL COATING ON PLANT VIRUS NANOPARTICLES FOR BIOIMAGING AND THERAPEUTIC APPLICATIONS
#128NOVEL COMPOUND, a-SYNUCLEIN AGGREGATE BINDER, AND USE THEREOF
#129CD206 Targeted Peptide Conjugates and Methods of Using the Same
#130RGD DIMER COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#131IMPLANTS AND BIODEGRADABLE TISSUE MARKERS
#132SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST MET
#133PROBE FOR NUCLEAR MEDICAL TESTING
#134IMPROVED ANTIBODY-PAYLOAD CONJUGATES (APCS) PREPARED BY SITE-SPECIFIC CONJUGATION UTILIZING GENETIC CODE EXPANSION
#135ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF
#136METHODS USING SURFACE-EXPRESSIBLE ACTIVATABLE EPITOPES TO LOCALIZE AND/OR TREAT DISEASED CELLS
#137IODIDE NANOPARTICLES AND COMPOSITIONS OF METHODS OF USE THEREOF
#138Methods for Biological Material Labeling and Medical Imaging
#139IMPROVED ALUMINUM FLUORIDE RADIOSYNTHESIS OF [18F]DK222
#140CHOLECYSTOKININ B RECEPTOR-TARGETED COMPLEX AND A CONTRAST AGENT THEREOF
#141FAP-ALPHA SPECIFIC TUMOR DIAGNOSTIC IMAGING AGENT
#142MULTIVALENT GLYCO-COMPLEX, IMAGING AGENT AND USES THEREOF
#143DUAL-TARGETING COMPOUND FOR FIBROBLAST ACTIVATION PROTEIN (FAP) AND INTEGRIN avB3, PREPARATION METHOD THEREFOR AND USE THEREOF
#144CELL-SURFACE ANTIBODY TO A SPECIFIC BIOMARKER OF PANCREATIC BETA-CELLS
#145DETECTION AND LOCALIZATION OF INTERNAL BLEEDING
#146THERAGNOSTIC FOLATE CONJUGATES
#147ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF
#148COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING
#149MASKED IL12 PROTEIN
#150MARKED FATTY ACID DERIVATIVE, PRECURSOR COMPOUND THEREOF, AND USE THEREOF IN CONTRAST AGENT
#151PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE
#152APTAMERS SPECIFIC TO EBV-ASSOCIATED MALIGNANCIES AND THEIR APPLICATIONS IN CANCER IMAGING AND THERAPIES
#153ANTI-B7-H3 COMPOUNDS AND METHODS OF USE
#154IIMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES
#155HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE
#156FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
#157SMALL MOLECULE INHIBITORS FOR EARLY DIAGNOSIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN CANCERS AND NEURODEGENERATIVE DISEASES
#158ZWITTERIONIC METAL CHELATORS
#159BIOMATERIAL COMPRISING POLY(ITACONATE-CO-DODECANEDIOL)
#160Methods for In Vivo Tracking of Cells
#161COMBINATIONS OF IMAGING AGENT CONJUGATES AND APPLICATION THEREOF
#162ZWITTERIONIC METAL CHELATORS
#163COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF
#164METHODS OF SCREENING FOR VMAT2 INHIBITORS
#165METHODS OF TREATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE
#166GLUTAMIC ACID -UREA COMPOUND, PREPARATION METHOD AND USE THEREOF, NUCLIDE-TARGETED PROBE, PREPARATION METHOD AND USE THEREOF, AND PHARMACEUTICAL COMPOSITION
#167LABELED COMPOUNDS AND CALCIUM SENSING RECEPTOR LIGANDS FOR IMAGING AND USES THEREOF
#168METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION
#169THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE
#170PET TRACERS FOR VISUALIZING GABAA GAMMA1 RECEPTORS
#171NEAR-INFRARED FLUORESCENT CONTRAST BIOIMAGING AGENTS FOR IMAGING OF SENTINEL LYMPH NODES
#172[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#173[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#174Formulations Comprising a SADA Complex
#175MICROFLUIDIC PREPARATION OF FLUOROCARBON CROSS-LINKED VESICLES
#176ANTI-BCMA NANOBODY AND USE THEREOF
#177HER2 AFFIBODY RADIONUCLIDE MARKER COMPOSITION AND APPLICATION THEREOF
#178LIGANDS AND THEIR USE
#179Medical Imaging of Glycogen Synthase Kinase-3 with a PET Probe
#180TISSUE-SPECIFIC IMAGING AND THERAPEUTIC AGENTS TARGETING PROTEINS EXPRESSED ON MUSCLE CELL SURFACE
#181SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES
#182NANOPARTICLES FOR POTENTIATING EFFECTS OF RADIATION THERAPY ON ANTI-CANCER IMMUNOTHERAPY
#183COMPOUNDS FOR USE IN NON-COVALENT SCAFFOLD AND METHODS RELATED THERETO
#184DOTA-HYNIC-iPSMA AS A THERAPEUTIC RADIOPHARMACEUTICAL TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#185Fluorescently Labeled Immunoglobulin Single Variable Domains
#186CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY
#187AGENTS, COMPOSITIONS, AND METHODS FOR CANCER DETECTION
#188RADIOLABELED COMPOUND, AND PRECURSOR COMPOUND THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#189NON-PEPTIDE TARGETED THERAPEUTICS AND USES THEREOF
#190NOVEL ANTIBODY SEQUENCES FOR DIAGNOSTICS AND THERAPEUTICS
#191GRANZYME B DIRECTED IMAGING AND THERAPY
#192DUAL-MODE PROBE FOR DETECTING HYDROGEN SULFIDE AND USE THEREOF
#193RADIOPHARMACEUTICALS, METHODS FOR THE PRODUCTION THEREOF, AND USES IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES
#194METHODS OF PREPARATION OF 18F LABELLED SILYL-FLUORIDE COMPOUNDS
#195HETEROBIVALENT AND HOMOBIVALENT AGENTS TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA AND/OR PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#196NON-METALLIC TEMPERATURE-RESPONSIVE COMPOSITE FOR MAGNETIC RESONANCE IMAGING (MRI), AND PREPARATION METHOD AND USE THEREOF
#1973D PRINTING OF SOLID-STATE PHANTOMS
#198TREATMENT OF PROSTATE CANCER WITH RADIOLABELED ANTIBODIES TARGETING CDCP1
#199RADIONUCLIDE LABELED POLYPEPTIDE CONJUGATES AND USES THEREOF
#200RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN
#201REAGENTS FOR SITE-SPECIFIC LABELING OF PROTEINS WITH RADIOHALOGENS, AND METHODS OF MAKING AND USING THE SAME
#202QUINOLINYL AND PRIDINYL CONTAINING COMPOUNDS TARGETING ON ALPHA-SYNUCLEIN FOR NEUROLOGICAL DISEASES
#203COMPOSITIONS AND METHODS OF FLUORESCEIN SODIUM FOR EARLY DIAGNOSIS OF CERVICAL CANCER
#204Netrin-1 detection, companion test and therapy based on radiations
#205NOVEL COMPOUND COMPRISING ESTER GROUP AND USES THEREOF
#206EXTRADOMAIN B FIBRONECTIN TARGETING PEPTIDES AND DERIVATIVES FOR CANCER IMAGING AND THERAPY
#207SYNTHETIC CYCLIC PEPTIDE MIMETICS
#208CARBONIC ANHYDRASE IX TARGETING AGENTS AND METHODS
#209ANTI-CLDN18.2 ANTIBODY CONJUGATES
#210ANTI-oxMIF RADIOIMMUNOCONJUGATE
#211CANCER THERANOSTIC COMPOSITIONS COMPRISING BIGUANIDE COMPLEXES OF GROUP 7 TRANSITION METALS AND USES THEREOF
#212Compounds For Molecular Imaging of Collagen Turnover and Methods Using Same
#213TRUNCATED EVANS BLUE MODIFIED FIBROBLAST ACTIVATION PROTEIN INHIBITOR, PREPARATION METHOD AND APPLICATION THEREOF
#214RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND THERANOSTIC USES THEREOF
#215FLUORESCENCE-MAGNETIC RESONANCE DUAL-MODALITY CONTRAST AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF
#216PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES
#217METHOD TO ASSESS NODAL DISEASE USING IRON OXIDE NANOPARTICLES IN MAGNETIC RESONANCE IMAGING
#218FOLATE RECEPTOR-TARGETED RADIOTHERAPEUTIC AGENTS AND THEIR USE
#219COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF
#220LUNG LESION LOCALIZATION MULTI-IMAGING CONTRAST AGENT COMPOSITION FOR RESTRICTIVE LUNG RESECTION
#221RADIOIMMUNOCONJUGATES DIRECTED TO NKG2D LIGANDS FOR THE TREATMENT OF CANCER
#222DEVELOPMENT OF CD163 TARGETING AGENT FOR IMAGING AND THERAPY
#223RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN
#224HER2 AFFIBODY 99MTC MARKER COMPOSITION AND APPLICATION THEREOF
#225HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#226Site-Specific Modification of Glycoproteins Through Transglutaminase-Mediated Conjugation
#227IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY
#228COMPOUNDS FOR BRAIN IMAGING
#229HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#230HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#231HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#232CONFORMATIONAL CONSTRAINED SOMATOSTATIN RECEPTOR 3 PEPTIDE LIGANDS AND THEIR CONJUGATES AND USES THEREOF
#233GRANZYME B DIRECTED IMAGING AND THERAPY
#234CONTRAST AGENT FOR DIAGNOSIS OF VASCULAR DISEASE CONTAINING GADOLINIUM-BASED COMPOUND AS ACTIVE INGREDIENT AND SYNTHESIS METHOD THEREFOR
#235BIOCOMPATIBLE RADIONUCLIDE-CONTAINING COMPOSITIONS AND METHODS OF USE
#236RADIOISOTOPE DELIVERY SYSTEM WITH MULTIPLE DETECTORS TO DETECT GAMMA AND BETA EMISSIONS
#237Loading of Alginate Microspheres
#238BIVALENT FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS
#239RADIOACTIVELY LABELED LIGAND FOR FIBROBLAST ACTIVATION PROTEIN-ALPHA IMAGING AGENT AND PREPARATION METHOD THEREFOR
#240NUCLIDE-LABELED INHIBITORY PEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#241FIBROBLAST ACTIVATION PROTEIN (FAP) INHIBITORS, FAP CONJUGATES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#242Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders
#243METHOD OF PREPARING ESTRADIOL DERIVATIVES BY SOLID-PHASE SYNTHESIS
#244PRECISE LABELING OF PROTEIN SCAFFOLDS WITH CARGO FOR USE IN BIOMEDICAL APPLICATIONS
#245COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY
#246IMPROVED CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY
#247Solid phase synthesis of glutamate-urea-lysine derived (GUL derived) prostate-specific membrane antigen (PSMA) targeting conjugates and their use as precursors for therapeutic and/or diagnostic agents
#248Molecular imaging complex for positron emission tomography
#249FUNCTIONALIZED SHIGA TOXIN B-SUBUNIT (STxB) PROTEINS AND CONJUGATES THEREOF
#250RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#251PSMA INHIBITOR, COMPOUND AND APPLICATION
#252LIGANDS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) CONTAINING HETEROAROMATIC LINKER BUILDING BLOCKS
#253METHODS OF DIAGNOSING AND PROGNOSING CANCERS OF THE HEAD AND NECK
#254ANTIBODIES
#255Truncated Evans Blue modified fibroblast activation protein inhibitor, preparation method and application thereof
#256RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE
#257E-SELECTIN TARGETING AGENTS
#258BINDING PROTEIN TARGETING HER2, PREPARATION METHOD AND USE THEREOF
#259FLUOROCARBON NANOEMULSIONS AND USES THEREOF IN IMAGING
#260BIOMATERIAL COMPRISING POLY(ITACONATE-CO-CITRATE-CO-OCTANEDIOL)
#261Method and device for direct production of radio-isotope based cancer treatment pharmaceuticals
#262PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING
#263PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY
#264RADIOISOTOPE LABELED COMPOUND FOR IMAGING OR TREATMENT OF PROSTATE CANCER
#265CARBON QUANTUM DOTS AND USES THEREOF
#266FORMULATIONS AND KITS FOR THE DIAGNOSTIC EVALUATION OF INFECTIOUS DISEASES AND METHODS THEREOF
#267Lipid microbubbles and process of making thereof
#268SOLVENT FREE GADOLINIUM CONTRAST AGENTS
#269Bifunctional do2pa derivatives, chelates with metallic cations and use thereof
#270ULTRAFINE IRON OXIDE NANOPARTICLE-BASED MAGNETIC RESONANCE IMAGING T1 CONTRAST AGENT
#271ONE STEP 64Cu-BaBaSar-RGD2 PRODUCTION METHOD
#272IMPLANTS AND BIODEGRADABLE TISSUE MARKERS
#273Tau PET imaging ligands
#274PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS
#275Half-curcuminoids as amyloid-beta pet imaging agents
#276Half-curcuminoids as amyloid-β PET imaging agents
#277ENHANCED SURGICAL VISUALIZATION OF VIABLE TISSUE AND PEPTIDES THEREFOR
#278Conformational restriction of cyanine fluorophores in far-red and near-IR range
#279Implant and biodegradable tissue marker compositions and methods
#280AZACYANINE DYES AND USE THEREOF
#2818-hydroxyquinoline derivatives as diagnostic and therapeutic agents
#282Biomaterial comprising poly(itaconate-co-citrate-co-octanediol)
#283CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE
#284Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#285Method for labeling radioisotope, radiolabeling compounds using quinone compound and kit comprising the same for labeling radioisotope
#286Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound
#287SALICYLIC ACID-BASED POLYMERIC CEST CONTRAST AGENTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF
#288PSMA ligands for imaging and endoradiotherapy
#289Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof
#290INCOMPATIBLE BLOOD GROUP ANTIGEN FOR CANCER DETECTION AND TREATMENT
#291Echolucent implant compositions and methods
#292Echolucent implant composition and methods
#293Echolucent implant compositions and methods
#294JCV IMAGING METHODS AND COMPOSITIONS
#295Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans
#296Conformational restriction of cyanine fluorophores in far-red and near-IR range
#2973,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents
#298Radioactive labeled long-acting peptide targeted pharmaceutical and production method thereof
#299Tumor targeted radionuclide therapy and molecular imaging of HER2+ cancers and other neoplasms
#300PRECISION MEDICINE THERANOSTICS AND DIAGNOSTICS A COMBINATION THEREOF